D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 20 900 KRW -1.88% Market Closed
Market Cap: 854.6B KRW
Have any thoughts about
Daewoong Co Ltd?
Write Note

Daewoong Co Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Co Ltd
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
D
Daewoong Co Ltd
KRX:003090
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
PP&E Gross
â‚©47.8B
CAGR 3-Years
25%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
PP&E Gross
â‚©96.5B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
6%
C
Celltrion Pharm Inc
KOSDAQ:068760
PP&E Gross
â‚©223.9B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
3%
No Stocks Found

Daewoong Co Ltd
Glance View

Market Cap
854.6B KRW
Industry
Pharmaceuticals

Daewoong Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Seongnam, Gyeonggi-Do. The firm operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Intrinsic Value
24 259.07 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

Back to Top